July 22, 2014 5:20 AM ET

Life Sciences Tools and Services

Company Overview of MerLion Pharmaceuticals Pte. Ltd.

Executive Profile

Swee Yeok Chu

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Mr. Swee Yeok Chu serves as the Chief Executive Officer of Bio*One Capital. Ms. Yeok has some two decades of investment & technology promotion as well as strategy and business development track record in the field. Ms. Yeok was instrumental in leading many successful negotiations with global pharmaceutical and biotechnology companies on their investments in Singapore. She serves as a Director of MerLion Pharmaceuticals Pte Ltd., S*BIO Pte Ltd., A-Bio Pharmaceuticals, ...

Corporate Headquarters

1 Science Park Road
Singapore, -- 117528

Singapore

Phone: 65 6829 5600
Fax: 65 6829 5601

Board Members Memberships

Director
Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MerLion Pharmaceuticals Pte. Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.